# ë°°ê²½ ìë£Œ: S8 ì„¸ê·  ê°ì—¼ ì§„ë‹¨ ë° ì¹˜ë£Œ

**ì„¸ì…˜**: S8 - Recent Advances in Diagnosis and Treatment of Bacterial Infections
**ì¼ì‹œ**: 2025ë…„ 10ì›” 27ì¼ (ì›”) 13:50-15:50
**ì¥ì†Œ**: Rm 301+302
**ì¤‘ìš”ë„**: â­â­â­â­â­ (98/100ì ) - **ìµœìš°ì„  í•„ìˆ˜!**

---

## ğŸ¯ ì„¸ì…˜ ê°œìš”

ì´ ì„¸ì…˜ì€ **AMR ì§„ë‹¨ ë° ì¹˜ë£Œì˜ ìµœì‹  ê¸°ìˆ **ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë„ì‹¬ AMR ê°ì‹œ ì—°êµ¬ì— **ì¦‰ì‹œ ì ìš© ê°€ëŠ¥í•œ í˜„ì¥ ì§„ë‹¨ ê¸°ìˆ **ì„ ë°°ìš¸ ìˆ˜ ìˆëŠ” ê°€ì¥ ì‹¤ìš©ì ì¸ ì„¸ì…˜ì…ë‹ˆë‹¤.

### ì™œ ì´ ì„¸ì…˜ì´ ìµœìš°ì„ ì¸ê°€?

- ğŸ”¬ **í˜„ì¥ ì§„ë‹¨ (Point-of-Care)**: ì‹¤í—˜ì‹¤ ì—†ì´ ë„ì‹¬ í˜„ì¥ì—ì„œ AMR ê²€ì¶œ
- âš¡ **ë¹ ë¥¸ ê²€ì¶œ**: ê¸°ì¡´ 48-72ì‹œê°„ â†’ 30ë¶„-2ì‹œê°„ìœ¼ë¡œ ë‹¨ì¶•
- ğŸ¦  **ê³µê¸° ì¤‘ AMR ê²€ì¶œ**: ë„ì‹¬ ëŒ€ê¸° ê°ì‹œì— ì§ì ‘ ì ìš© ê°€ëŠ¥
- ğŸ’¡ **í˜ì‹ ì  í”Œë«í¼**: Fidget spinner, Cell-free system, Graphene FET

---

## ğŸ“‹ ë°œí‘œë³„ ìƒì„¸ ë¶„ì„

### ğŸ”¹ ë°œí‘œ 1 (13:50-14:15)

**ì—°ì‚¬**: Jeong Wook Lee (ì´ì •ìš±)
**ì†Œì†**: POSTECH (Pohang University of Science and Technology)
**ì œëª©**: Cell-free transcription cascades for rapid RNA detection and SNP discrimination

#### ìµœê·¼ ì—°êµ¬ ë°°ê²½

Lee êµìˆ˜íŒ€ì€ **COVID-19 ì§„ë‹¨ì„ ìœ„í•œ í˜ì‹ ì ì¸ cell-free RNA ê²€ì¶œ ê¸°ìˆ  SENSR**ì„ ê°œë°œí–ˆìŠµë‹ˆë‹¤.

**SENSR (SENsitive Splint-based one-pot isothermal RNA detection)**:
- **2020ë…„ Nature Biomedical Engineering** ê²Œì¬
- 30-50ë¶„ ë§Œì— RNA ê²€ì¶œ (RT-PCR ëŒ€ë¹„ ë¹ ë¦„)
- 0.1 attomolar ê²€ì¶œ í•œê³„ (ì´ˆê³ ê°ë„)
- 40ê°œ nasopharyngeal ìƒ˜í”Œ: 95% PPV, 100% NPV

**í•µì‹¬ ë©”ì»¤ë‹ˆì¦˜**:
```
1. Probe hybridization (í‘œì  RNA ê²°í•©)
   â†“
2. SplintR ligase (Ligation)
   â†“
3. T7 RNA polymerase (Transcription cascade)
   â†“
4. Fluorogenic dye binding (Signal amplification)
   â†“
5. Fluorescence detection (30-50ë¶„)
```

**íŠ¹ì§•**:
- **One-pot reaction**: ëª¨ë“  ë°˜ì‘ì´ í•œ íŠœë¸Œì—ì„œ
- **Isothermal**: ì¼ì • ì˜¨ë„ (37-42Â°C) - PCRì²˜ëŸ¼ thermal cycling ë¶ˆí•„ìš”
- **SNP discrimination**: Single nucleotide polymorphism êµ¬ë³„ ê°€ëŠ¥

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Cell-free Transcription Cascadeë€?**

ì „í†µì  ë°©ë²• vs. SENSR:
| ë°©ë²• | ì‹œê°„ | ë¯¼ê°ë„ | ì¥ë¹„ | SNP êµ¬ë³„ |
|------|------|--------|------|----------|
| RT-qPCR | 2-4ì‹œê°„ | ë†’ìŒ | Thermal cycler | ê°€ëŠ¥ (melting curve) |
| LAMP | 1-2ì‹œê°„ | ë†’ìŒ | Heat block | ì–´ë ¤ì›€ |
| **SENSR** | 30-50ë¶„ | ì´ˆê³ ê°ë„ | ë‹¨ìˆœ (í˜•ê´‘ ë¦¬ë”) | ê°€ëŠ¥ |

**2. ì‘ë™ ì›ë¦¬**

**Key Components**:
- **Splint probes**: í‘œì  RNA íŠ¹ì´ì  ê²°í•©
- **SplintR ligase**: RNA ligase (thermostable)
- **T7 RNA polymerase**: Transcription amplification
- **RNA aptamer + fluorogenic dye**: Signal generation

**Cascade Amplification**:
- Ligation â†’ 1 ligated product
- T7 transcription â†’ ìˆ˜ë°±~ìˆ˜ì²œ copies RNA
- Each RNA â†’ Fluorescence signal
- **Exponential amplification**

**3. SNP Discrimination**

**ì¤‘ìš”ì„±**:
- AMR mutation ê²€ì¶œ (e.g., rpoB S531L in rifampin-resistant TB)
- Strain typing
- Virulence gene variants

**ë©”ì»¤ë‹ˆì¦˜**:
- Splint probeê°€ perfect matchì—ë§Œ ligation í—ˆìš©
- Single mismatch â†’ No ligation â†’ No signal
- **Allele-specific detection**

**4. ì„¸ê·  ê°ì—¼ ì§„ë‹¨ ì‘ìš©**

COVID-19 ì™¸ ì‘ìš©:
- **Bacterial pathogens**: 16S rRNA detection
- **AMR genes**: mecA, blaKPC, blaNDM
- **Toxin genes**: Shiga toxin (stx1/stx2), Cholera toxin
- **Multiplex detection**: ì—¬ëŸ¬ í‘œì  ë™ì‹œ ê²€ì¶œ

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë„ì‹¬ AMR ê°ì‹œì— ì ìš©**:

**1. í˜„ì¥ RNA ê²€ì¶œ**:
- **ë©”íƒ€ì „ì‚¬ì²´ ìƒ˜í”Œ**: ë„ì‹¬ ëŒ€ê¸°/ë¬¼/í† ì–‘ì—ì„œ RNA ì¶”ì¶œ
- SENSRë¡œ **AMR gene transcripts** ê²€ì¶œ
  - mecA (MRSA)
  - blaNDM, blaKPC (carbapenemase)
  - erm genes (macrolide resistance)
- **Active AMR ê²€ì¶œ**: DNAê°€ ì•„ë‹Œ RNA = actively expressed genes

**2. SNP-based AMR detection**:
- **Point mutations** ê²€ì¶œ:
  - rpoB mutations (rifampin resistance)
  - gyrA/gyrB (fluoroquinolone resistance)
  - 23S rRNA (macrolide resistance)
- ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ë¡œ variant ë°œê²¬ â†’ SENSRë¡œ í˜„ì¥ ê²€ì¦

**3. Portable platform**:
- **Battery-powered fluorescence reader**
- ë„ì‹¬ í˜„ì¥ (ì§€í•˜ì² ì—­, ë³‘ì›, ìˆ˜ì²˜ë¦¬ì¥)ì—ì„œ ì¦‰ì‹œ ê²€ì‚¬
- 30-50ë¶„ â†’ **ì‹¤ì‹œê°„ AMR ê°ì‹œ ê°€ëŠ¥**

**4. Multiplex AMR panel**:
```yaml
Urban AMR SENSR Panel:
  Gram-positive:
    - mecA (MRSA)
    - vanA/vanB (VRE)
  Gram-negative:
    - blaNDM (Carbapenemase)
    - blaKPC (Carbapenemase)
    - mcr-1 (Colistin resistance)
  Mycobacteria:
    - rpoB S531L (Rifampin-R TB)
```

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Cell-free Systems**
- **ì •ì˜**: ì„¸í¬ ì—†ì´ ìƒí™”í•™ ë°˜ì‘ë§Œ ìˆ˜í–‰
- **ì¥ì **:
  - ë¹ ë¦„ (ì„¸í¬ ë°°ì–‘ ë¶ˆí•„ìš”)
  - ì¡°ì‘ ìš©ì´ (ë°˜ì‘ ì¡°ê±´ ìµœì í™”)
  - ì•ˆì „ (ì‚´ì•„ìˆëŠ” ë³‘ì›ì²´ ë¶ˆí•„ìš”)
- **ë‹¨ì **:
  - íš¨ì†Œ ë¹„ìš©
  - ì•ˆì •ì„± (cold chain í•„ìš”)

**2. T7 RNA Polymerase**
- **ìœ ë˜**: Bacteriophage T7
- **íŠ¹ì„±**:
  - ë§¤ìš° ë¹ ë¥¸ transcription (ì†ë„: E. coli RNAPì˜ 5ë°°)
  - T7 promoter íŠ¹ì´ì„± (ê³ íŠ¹ì´ì„±)
  - **In vitro transcription (IVT)ì˜ í‘œì¤€**
- **ì‘ìš©**: mRNA ë°±ì‹  (Pfizer, Moderna), RNA probe í•©ì„±

**3. SplintR Ligase**
- **RNA ligase**: RNA-RNA ligation
- **Thermostable**: ê³ ì˜¨ì—ì„œ ì•ˆì •
- **Splinted ligation**:
  - Splint (guide) RNAê°€ ë‘ RNAë¥¼ ì •ë ¬
  - Perfect match í•„ìš” â†’ SNP discrimination

**4. Isothermal Amplification Methods**

ë¹„êµ:
| ë°©ë²• | ì˜¨ë„ | ì‹œê°„ | ë³µì¡ë„ | SNP êµ¬ë³„ |
|------|------|------|--------|----------|
| **LAMP** | 60-65Â°C | 30-60ë¶„ | ì¤‘ê°„ | ì–´ë ¤ì›€ |
| **RPA** | 37-42Â°C | 10-20ë¶„ | ë‚®ìŒ | ì–´ë ¤ì›€ |
| **SENSR** | 37-42Â°C | 30-50ë¶„ | ì¤‘ê°„ | **ê°€ëŠ¥** |

**5. Fluorogenic Dyes & RNA Aptamers**
- **RNA aptamer**: RNA that binds specific molecules
- **Malachite green aptamer**: Binds malachite green â†’ í˜•ê´‘ ì¦ê°€
- **Spinach aptamer**: Binds DFHBI â†’ GFP-like fluorescence
- **Signal-to-noise ratio**: Background ë‚®ìŒ (unbound dye = low fluorescence)

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸** (ìš°ì„ ìˆœìœ„):

1. "**ë©”íƒ€ì „ì‚¬ì²´ ìƒ˜í”Œ** (ë„ì‹¬ ëŒ€ê¸°ì—ì„œ ì¶”ì¶œí•œ ì´ RNA)ì— SENSRë¥¼ ì§ì ‘ ì ìš©í•  ìˆ˜ ìˆë‚˜ìš”? Pre-amplification í•„ìš”í•œê°€ìš”?"

2. "**Multiplex SENSR**ë¡œ ì—¬ëŸ¬ AMR genesë¥¼ ë™ì‹œ ê²€ì¶œí•  ë•Œ, ìµœëŒ€ ëª‡ ê°œ íƒ€ê²Ÿê¹Œì§€ ê°€ëŠ¥í•œê°€ìš”? (ë‹¤ë¥¸ fluorophores ì‚¬ìš©?)"

3. "SENSRë¡œ **ì •ëŸ‰ ë¶„ì„** (qSENSR?)ì´ ê°€ëŠ¥í•œê°€ìš”? AMR gene transcript abundanceë¥¼ ì¸¡ì •í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤."

4. "**False positive**ë¥¼ ìœ ë°œí•  ìˆ˜ ìˆëŠ” ìš”ì¸ì€? í™˜ê²½ ìƒ˜í”Œì˜ inhibitors (humic acid, polysaccharides) ì˜í–¥?"

5. "Commercial kit ê°œë°œ ê³„íšì´ ìˆë‚˜ìš”? **Point-of-care device** í˜•íƒœë¡œ?"

**í† ë¡  ì˜ˆìƒ**:
- **CRISPR-based detection (SHERLOCK, DETECTR)** vs. SENSR ë¹„êµ
- **Lyophilization** (ë™ê²°ê±´ì¡°) ê°€ëŠ¥ì„± â†’ Cold chain ì—†ì´ ë³´ê´€
- **Cost per test**: RT-PCR ëŒ€ë¹„ ê²½ì œì„±?
- **Sensitivity in complex matrices**: Soil, wastewater, air samples

**ë„¤íŠ¸ì›Œí‚¹**:
- POSTECHëŠ” KRIBB, UNISTì™€ ê°€ê¹Œì›€ (í¬í•­-ìš¸ì‚°-ëŒ€ì „)
- Collaborative study ì œì•ˆ: "Urban air AMR surveillance with SENSR"

---

### ğŸ”¹ ë°œí‘œ 2 (14:15-14:40) â­ **ë„ì‹¬ AMR ê°ì‹œ í•µì‹¬!**

**ì—°ì‚¬**: Eun-Kyung Lim (ì„ì€ê²½)
**ì†Œì†**: KRIBB (Korea Research Institute of Bioscience & Biotechnology)
**ì œëª©**: Portable biosensing platforms for onsite detection of airborne antibiotic-resistant bacteria

#### ìµœê·¼ ì—°êµ¬ ë°°ê²½

Lim ë°•ì‚¬ëŠ” **KRIBBì—ì„œ ë°”ì´ì˜¤ì„¼ì„œ ê°œë°œ**ì„ ì£¼ë„í•˜ê³  ìˆìœ¼ë©°, **2025ë…„ íšê¸°ì ì¸ ì—°êµ¬**ë¥¼ ë°œí‘œí–ˆìŠµë‹ˆë‹¤.

**í•µì‹¬ ì—°êµ¬: CN-TAR Assay (2025)**

**ì œëª©**: "Onsite detection of airborne antibiotic-resistant bacteria via Cas9 nickase-triggered amplification reactions"

**CN-TAR = Cas9 Nickase-Triggered Amplification Reaction**

**ì„±ëŠ¥**:
- **MRSA ê²€ì¶œ í•œê³„**: 1.40 copies/Î¼L
- **VRE ê²€ì¶œ í•œê³„**: 1.13 copies/Î¼L
- **Turnaround time**: Real-time (ë“±ì˜¨ ë°˜ì‘)
- **Portable**: Isothermal PCR device í†µí•©

**í˜ì‹ ì„±**:
- **Cas9 nickase**: DNAì˜ í•œ ê°€ë‹¥ë§Œ ì ˆë‹¨ (double-strand ì•„ë‹˜)
- **Rolling Circle Amplification (RCA)**: ì§€ìˆ˜ì  ì¦í­
- **Single-step detection**: ë³µì¡í•œ workflow ì—†ìŒ
- **ê³µê¸° ìƒ˜í”Œ ê²€ì¦**: Actual airborne samples tested!

**Validation**:
- Synthetic nucleic acids âœ“
- Cultured bacteria âœ“
- **Airborne samples** âœ“ â† ì‹¤ì œ í™˜ê²½ ê²€ì¦!
- RT-PCRì™€ comparable sensitivity

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. ê³µê¸° ì¤‘ í•­ìƒì œ ë‚´ì„±ê· ì˜ ì¤‘ìš”ì„±**

**ë¬¸ì œ**:
- **ë³‘ì› ê°ì—¼**: ê³µê¸° ë§¤ê°œ MRSA, VRE ì „íŒŒ
- **ì§€ì—­ì‚¬íšŒ í™•ì‚°**: ëŒ€ì¤‘êµí†µ, í•™êµ, ì‚¬ë¬´ì‹¤
- **ì¶•ì‚° í™˜ê²½**: MRSA ST398 (livestock-associated)
- **í•­ìƒì œ ë‚´ì„± ìœ ì „ì ì „íŒŒ**: Airborne horizontal gene transfer

**í˜„ì¬ ë°©ë²•ì˜ í•œê³„**:
| ë°©ë²• | ì‹œê°„ | ë¯¼ê°ë„ | í˜„ì¥ ì‚¬ìš© |
|------|------|--------|-----------|
| Culture | 24-72ì‹œê°„ | ì¤‘ê°„ | âŒ |
| PCR | 3-5ì‹œê°„ | ë†’ìŒ | âŒ (ì¥ë¹„ í•„ìš”) |
| qPCR | 2-3ì‹œê°„ | ë§¤ìš° ë†’ìŒ | âŒ |
| **CN-TAR** | <2ì‹œê°„ | ë§¤ìš° ë†’ìŒ | âœ… **Portable!** |

**2. CN-TAR Assay ë©”ì»¤ë‹ˆì¦˜**

**Step-by-step**:
```
1. Air sampling
   â†“ (Filter collection)
2. DNA extraction (ê°„ë‹¨í•œ lysis)
   â†“
3. Cas9 nickase target recognition
   â†“ (mecA or vanA gene)
4. Single-strand cleavage (nick ìƒì„±)
   â†“
5. Rolling Circle Amplification (RCA)
   â†“ (Phi29 polymerase)
6. Real-time fluorescence detection
   â†“
7. Result (30-90ë¶„)
```

**í•µì‹¬ êµ¬ì„±ìš”ì†Œ**:
- **Cas9 nickase (D10A mutant)**:
  - Normal Cas9: Double-strand break
  - **Nickase**: Single-strand nickë§Œ
  - â†’ RCAì˜ starting point
- **Guide RNA (gRNA)**:
  - mecA-specific gRNA (MRSA)
  - vanA-specific gRNA (VRE)
  - **Specificity**: Single nucleotide discrimination
- **Phi29 DNA polymerase**:
  - RCA workhorse
  - High processivity (ìˆ˜ë§Œ nucleotides)
  - Strand displacement
- **Circular template**:
  - Rolling circle
  - ì§€ìˆ˜ì  ì¦í­ (exponential)

**3. Portable Isothermal PCR Device**

**íŠ¹ì§•**:
- **Battery-powered**: ì „ì› ë¶ˆí•„ìš”
- **Compact**: Handheld size
- **Real-time monitoring**: Fluorescence detection
- **Temperature control**: 37Â°C ìœ ì§€ (ë“±ì˜¨)

**Workflow**:
```
[Air sampler] â†’ [Filter] â†’ [Lysis] â†’ [CN-TAR device] â†’ [Result]
   (10ë¶„)        (5ë¶„)      (5ë¶„)       (60-90ë¶„)        (ì¦‰ì‹œ)
```

**Total time**: ~2ì‹œê°„ (vs. culture 48-72ì‹œê°„)

**4. ê²€ì¦ ê²°ê³¼**

**Airborne sample testing**:
- ë³‘ì› í™˜ê²½
- ì¶•ì‚° ì‹œì„¤
- ì§€ì—­ì‚¬íšŒ (í•™êµ, ì§€í•˜ì² ?)

**Performance**:
- **Specificity**: 100% (non-target bacteriaì— ë°˜ì‘ ì—†ìŒ)
- **Sensitivity**: 1-2 copies/Î¼L (ultra-sensitive)
- **False positives**: Minimal
- **Cross-reactivity**: None

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë„ì‹¬ AMR ê°ì‹œì˜ ì™„ë²½í•œ ë„êµ¬!**

**1. ë„ì‹¬ ëŒ€ê¸° AMR ëª¨ë‹ˆí„°ë§**:

**ìƒ˜í”Œë§ ì „ëµ**:
```yaml
Location Types:
  High-risk:
    - ì§€í•˜ì² ì—­ (í™˜ê¸° ë¶ˆëŸ‰)
    - ë³‘ì› (ì‘ê¸‰ì‹¤, ì¤‘í™˜ìì‹¤)
    - ìš”ì–‘ì›
  Medium-risk:
    - í•™êµ, ì–´ë¦°ì´ì§‘
    - ëŒ€í˜• ì‡¼í•‘ëª°
    - ì‚¬ë¬´ì‹¤ ê±´ë¬¼
  Baseline:
    - ê³µì› (outdoor)
    - ì£¼ê±° ì§€ì—­

Sampling Schedule:
  - Peak hours (ì¶œí‡´ê·¼ ì‹œê°„)
  - Seasonal variation
  - Before/after cleaning
```

**2. CN-TAR Panel for Urban AMR**:

**í™•ì¥ ê°€ëŠ¥í•œ íƒ€ê²Ÿ**:
```yaml
Current (Lim's study):
  - mecA (MRSA)
  - vanA/vanB (VRE)

Expandable:
  Gram-negative AMR:
    - blaNDM, blaKPC (Carbapenemase)
    - mcr-1 (Colistin)
  Respiratory pathogens:
    - M. tuberculosis (rpoB mutations)
  Toxins:
    - Shiga toxin genes
```

**3. Metagenomics + CN-TAR í†µí•©**:

**Workflow**:
```
Step 1: ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ (ì£¼ 1íšŒ)
  â†“
  - Community profiling
  - AMR gene discovery
  - Novel variants

Step 2: CN-TAR (ë§¤ì¼/ì‹¤ì‹œê°„)
  â†“
  - ì£¼ìš” AMR genes targeted monitoring
  - Rapid outbreak detection
  - Hotspot identification
```

**Synergy**:
- Metagenomics = Broad discovery
- CN-TAR = Targeted, real-time monitoring

**4. Public Health Application**:

**Alert System**:
```
CN-TAR threshold > X copies/mÂ³
  â†“
  Alert to public health authority
  â†“
  Enhanced cleaning/ventilation
  â†“
  Follow-up sampling (24h later)
  â†“
  Confirm clearance
```

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Cas9 Nuclease vs. Nickase**

| Type | Activity | DSB | Application |
|------|----------|-----|-------------|
| **Cas9 (wild-type)** | Endonuclease | Yes (ì–‘ ê°€ë‹¥ ì ˆë‹¨) | Gene editing |
| **Cas9 D10A nickase** | Nickase | No (í•œ ê°€ë‹¥ë§Œ) | **Diagnostics, RCA** |
| **dCas9** | None | No | Transcription regulation |

**Why nickase for diagnostics?**
- Nick = RCA initiation point
- íŠ¹ì´ì„± ë†’ìŒ (gRNA-dependent)
- Safety (genomic editing risk ì—†ìŒ)

**2. Rolling Circle Amplification (RCA)**

**ë©”ì»¤ë‹ˆì¦˜**:
```
Circular template (100-200 nt)
    â†“
Primer annealing (Nickê°€ primer ì—­í• )
    â†“
Phi29 polymerase extension
    â†“
Strand displacement
    â†“
Continuous synthesis (ìˆ˜ì²œ-ìˆ˜ë§Œ nt)
    â†“
Long ssDNA product (concatemer)
```

**ì¥ì **:
- **Isothermal** (30-37Â°C)
- **High sensitivity** (single molecule detection)
- **Simple**: Thermal cycling ë¶ˆí•„ìš”

**ë‹¨ì **:
- Circular template ì œì‘ í•„ìš”
- Background ê´€ë¦¬

**3. Air Sampling for Bacteria**

**Methods**:
| Method | Principle | Sample Volume | Pros | Cons |
|--------|-----------|---------------|------|------|
| **Impaction** | Air â†’ Agar plate | 100-1000 L | Culture ì§ì ‘ | Viable only |
| **Filtration** | Air â†’ Filter | 100-10,000 L | **DNA ì¶”ì¶œ ê°€ëŠ¥** | Requires extraction |
| **Impingement** | Air â†’ Liquid | 100-1000 L | Gentle (viability) | Volume ì œí•œ |
| **Electrostatic** | Charged particles | ìˆ˜ì²œ L | High volume | ê³ ê°€ |

**For CN-TAR**: **Filtration** ìµœì 
- Filter pore size: 0.22-0.45 Î¼m
- Flow rate: 10-30 L/min
- Sampling time: 10-60ë¶„
- â†’ 100-1800 L air volume

**4. Antibiotic Resistance Genes in Air**

**Sources**:
- **Human shedding**: Skin, respiratory droplets
- **Fomites resuspension**: Dust, surfaces
- **Wastewater aerosols**: Treatment plants
- **Livestock**: Farms, slaughterhouses

**Persistence**:
- DNA: Days to weeks (in dust)
- Viable bacteria: Hours to days
- **Spores**: Months (Bacillus, Clostridium)

**Factors**:
- Humidity (higher = longer survival)
- UV radiation (shorter survival)
- Temperature
- Airborne particulate matter (PM2.5, PM10)

**5. Portable Diagnostics Criteria**

**ASSURED (WHO)**:
- **Affordable**: <$10 per test
- **Sensitive**: Low detection limit
- **Specific**: No cross-reactivity
- **User-friendly**: Minimal training
- **Rapid & Robust**: <2h, field conditions
- **Equipment-free**: Minimal instrumentation
- **Deliverable**: Accessible to end-users

**CN-TAR**: Meets most criteria!
- Sensitive âœ“
- Specific âœ“
- Rapid âœ“ (2h)
- Robust âœ“
- Equipment: Minimal (portable device)
- Cost: TBD

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸** (ìµœìš°ì„ !):

1. "**ë„ì‹¬ ëŒ€ê¸° ìƒ˜í”Œ**ì—ì„œ ì–´ë–¤ air sampling ë°©ë²•ì„ ì‚¬ìš©í–ˆë‚˜ìš”? Filter typeê³¼ sampling volumeì€?"

2. "CN-TARë¥¼ **multiplex** (mecA + vanA + blaNDM ë™ì‹œ ê²€ì¶œ)ë¡œ í™•ì¥í•  ìˆ˜ ìˆë‚˜ìš”? ì—¬ëŸ¬ gRNAë¥¼ í•œ ë°˜ì‘ì—?"

3. "**Portable deviceì˜ ë¹„ìš©**ì€ ì–¼ë§ˆë‚˜ ë˜ë‚˜ìš”? ê·¸ë¦¬ê³  per-test reagent costëŠ”? (Public health surveillance budget ê³ ë ¤)"

4. "**Quantitative** CN-TARê°€ ê°€ëŠ¥í•œê°€ìš”? Airborne AMR bacteriaì˜ **ë†ë„** (CFU/mÂ³ ë˜ëŠ” copies/mÂ³)ë¥¼ ì •ëŸ‰í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤."

5. "í™˜ê²½ ìƒ˜í”Œì˜ **inhibitors** (dust, PM2.5, humic substances) ì˜í–¥ì€ ì–´ë–»ê²Œ ê·¹ë³µí–ˆë‚˜ìš”?"

6. "**Real-world deployment** ê²½í—˜ì´ ìˆë‚˜ìš”? ë³‘ì›ì´ë‚˜ public spaceì—ì„œ pilot study?"

**Collaboration ì œì•ˆ**:
"ì €ëŠ” **ë„ì‹¬ ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ AMR ê°ì‹œ**ë¥¼ í•˜ê³  ìˆìŠµë‹ˆë‹¤. CN-TARë¥¼ ì„œìš¸ ì§€í•˜ì² /ë³‘ì›ì— ì ìš©í•˜ëŠ” collaborative studyì— ê´€ì‹¬ ìˆìœ¼ì‹ ê°€ìš”?"

**í† ë¡  ì˜ˆìƒ**:
- **CRISPR diagnostics** ë‹¤ë¥¸ í”Œë«í¼ê³¼ ë¹„êµ:
  - SHERLOCK (Cas13)
  - DETECTR (Cas12)
  - **CN-TAR (Cas9n + RCA)** â† Unique!
- **Commercial development**: Startup? Licensing?
- **Regulatory approval**: In vitro diagnostic (IVD) ì¸ì¦?
- **Data integration**: CN-TAR + metagenomics + epidemiology

**ë„¤íŠ¸ì›Œí‚¹ ì „ëµ**:
- â­â­â­ **ìµœìš°ì„  ë„¤íŠ¸ì›Œí‚¹ ëŒ€ìƒ!**
- ë°œí‘œ ì§í›„ ì§ˆë¬¸ (air sampling method)
- Coffee break/Poster session: "Collaborative study ì œì•ˆì„œ ë³´ë‚´ë“œë¦¬ê³  ì‹¶ìŠµë‹ˆë‹¤"
- Follow-up email (3ì¼ ë‚´): Specific proposal with preliminary data
- KRIBB ë°©ë¬¸ ì œì•ˆ: "Lab tour & research discussion"

---

### ğŸ”¹ ë°œí‘œ 3 (14:40-15:05) â­ **í˜ì‹ ì  í”Œë«í¼!**

**ì—°ì‚¬**: Yoon-Kyoung Cho (ì¡°ìœ¤ê²½)
**ì†Œì†**: UNIST (Ulsan National Institute of Science and Technology), Department of Biomedical Engineering
**ì œëª©**: Fidget spinner platforms for rapid bacterial detection

#### ìµœê·¼ ì—°êµ¬ ë°°ê²½

Cho êµìˆ˜ëŠ” **ë†€ë¼ìš´ ì•„ì´ë””ì–´ë¡œ ì„¸ê³„ì  ì£¼ëª©**ì„ ë°›ì•˜ìŠµë‹ˆë‹¤: **ì¥ë‚œê° í”¼ì ¯ ìŠ¤í”¼ë„ˆë¥¼ ì§„ë‹¨ ë„êµ¬ë¡œ ë³€í™˜!**

**ìµœì‹  ì—°êµ¬: Plasmonic Fidget Spinner (2025)**

**ì œëª©**: "Nanoplasmonic SERS on fidget spinner for digital bacterial identification"
**ê²Œì¬**: Microsystems & Nanoengineering (2025ë…„ 3ì›” 3ì¼)

**P-FS = Plasmonic Fidget Spinner**

**êµ¬ì„±**:
- Fidget spinner (ì†ìœ¼ë¡œ íšŒì „)
- Nitrocellulose membrane (ë°•í…Œë¦¬ì•„ ì—¬ê³¼)
- **Nanoplasmonic-enhanced matrix** (metallic features)
- **SERS (Surface-Enhanced Raman Spectroscopy)**

**ì„±ëŠ¥**:
- **ê²€ì¶œ ì‹œê°„**: ìˆ˜ ë¶„ (culture ëŒ€ë¹„ ìˆ˜ë°± ë°° ë¹ ë¦„)
- **ê·  ì¢… êµ¬ë³„**: E. coli vs. S. aureus (vibrational fingerprints)
- **ì‹¤ì œ ìƒ˜í”Œ**: Urine (UTI ì§„ë‹¨)
- **ì „ê¸° ë¶ˆí•„ìš”**: Hand-powered! (ìì› ì œí•œ ì§€ì—­ì— ì´ìƒì )

**ì´ì „ ì—°êµ¬ (2020, Nature Biomedical Engineering)**:
- "A fidget spinner for the point-of-care diagnosis of urinary tract infection"
- UTI ì§„ë‹¨ (E. coli in urine)
- 70ë¶„ â†’ ì§„ë‹¨ ì™„ë£Œ
- Sensitivity/specificity > 90%

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Fidget Spinnerì˜ ì§„ë‹¨ í™œìš© - ì™œ?**

**ê¸°ì¡´ ì§„ë‹¨ì˜ ë¬¸ì œ**:
- **Culture**: 24-72ì‹œê°„
- **PCR**: ê³ ê°€ ì¥ë¹„, ì „ê¸° í•„ìš”
- **Flow cytometry**: ë” ê³ ê°€, ì „ë¬¸ê°€ í•„ìš”

**ìì› ì œí•œ í™˜ê²½ (LMICs - Low/Middle Income Countries)**:
- ì „ê¸° ë¶ˆì•ˆì •
- ì›ì‹¬ë¶„ë¦¬ê¸° ì—†ìŒ
- Refrigeration ì—†ìŒ

**Fidget Spinner ì¥ì **:
- **Centrifugal force** (íšŒì „ë ¥ìœ¼ë¡œ separation)
- **No electricity**
- **Portable**: Pocket-size
- **Cheap**: ~$1-5 (vs. centrifuge $1000+)
- **User-friendly**: êµìœ¡ ìµœì†Œ

**2. ì‘ë™ ì›ë¦¬**

**Version 1 (2020): UTI Diagnosis**

```
Sample (Urine)
  â†“
Add to spinner chamber
  â†“
Spin (1-2ë¶„, hand-powered)
  â†“ (Centrifugal force)
Bacteria pellet (bottom)
  â†“
Add lysis buffer + DNA binding beads
  â†“
Spin again
  â†“
DNA captured on beads
  â†“
Wash (spin)
  â†“
LAMP amplification (isothermal)
  â†“
Fluorescence detection (70ë¶„ total)
```

**Version 2 (2025): Plasmonic Fidget Spinner (P-FS)**

**Core Innovation**: **SERS (Surface-Enhanced Raman Spectroscopy)**

```
Sample (Urine, Blood, Environmental)
  â†“
Pass through spinner (íšŒì „í•˜ë©° filtration)
  â†“
Bacteria captured on nanoplasmonic membrane
  â†“ (Nitrocellulose + metallic nanostructures)
Raman spectroscopy
  â†“ (Laser excitation)
Vibrational fingerprint acquisition
  â†“
Machine learning classification
  â†“
Species identification (ìˆ˜ ë¶„)
```

**3. SERS (Surface-Enhanced Raman Spectroscopy)**

**Raman Spectroscopy ê¸°ë³¸**:
- **ì›ë¦¬**: ë¶„ìì˜ vibrational modes ì¸¡ì •
- Laser â†’ ìƒ˜í”Œ â†’ Inelastic scattering
- **Fingerprint**: ê° ë¶„ì/ê· ì¢…ë§ˆë‹¤ unique spectrum

**SERS Enhancement**:
- **Metallic nanostructures** (Au, Ag nanoparticles)
- Localized surface plasmon resonance (LSPR)
- **Enhancement factor**: 10â¶-10â¸ Ã—
- â†’ Single molecule detection ê°€ëŠ¥

**Bacterial SERS**:
- **Cell wall components**: Peptidoglycan, teichoic acids
- **Proteins**: Surface proteins
- **Lipids**: Membrane lipids
- **DNA/RNA** (if lysed)

**Species discrimination**:
| Bacteria | Characteristic Raman Peaks |
|----------|----------------------------|
| **E. coli** | 1380 cmâ»Â¹ (DNA), 730 cmâ»Â¹ (adenine) |
| **S. aureus** | 1450 cmâ»Â¹ (CHâ‚‚ bend), 1003 cmâ»Â¹ (phenylalanine) |
| **P. aeruginosa** | 1600 cmâ»Â¹ (amide I), pyocyanin peaks |

**4. Nanoplasmonic-Enhanced Matrix**

**Fabrication**:
- Nitrocellulose membrane (porous)
- Metal deposition (Au or Ag nanoparticles)
- Optimized spacing for "hot spots"

**Function**:
- **Filtration**: Bacteria captured
- **SERS enhancement**: Plasmonic hot spots
- **Integration**: Fidget spinnerì— ì¥ì°©

**5. Machine Learning Classification**

**Workflow**:
```
SERS spectrum (ìˆ˜ë°±-ìˆ˜ì²œ data points)
  â†“
Preprocessing (baseline correction, normalization)
  â†“
Feature extraction (Peak positions, intensities)
  â†“
ML model (SVM, Random Forest, CNN)
  â†“
Species prediction (E. coli, S. aureus, etc.)
```

**Training**:
- Reference strain spectra (ATCC strains)
- Clinical isolates
- **Accuracy**: >95% (2-3 species)

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë„ì‹¬ í™˜ê²½ AMR ê°ì‹œì— í˜ëª…ì !**

**1. Portable Environmental Monitoring**:

**Use Cases**:
```yaml
Urban Water Monitoring:
  - ì§€í•˜ì²  ê³µê¸°
  - ë³‘ì› í™˜ê¸°êµ¬
  - í•˜ìˆ˜ ì²˜ë¦¬ì¥ ìœ ì¶œìˆ˜
  - ê³µê³µ í™”ì¥ì‹¤ ìˆ˜ë„ê¼­ì§€

Sample Processing:
  1. Collect sample (water, air filter rinse)
  2. Spin on P-FS (1-2ë¶„)
  3. SERS measurement (5-10ë¶„)
  4. Species ID + AMR prediction
```

**2. SERS-based AMR Detection**:

**ê°€ëŠ¥ì„±**:
- **Phenotypic resistance**: Cell wall changes in resistant strains
  - MRSA vs. MSSA (mecA â†’ altered PBP2a â†’ cell wall structure)
  - VRE vs. VSE (vancomycin â†’ D-Ala-D-Lac)
- **SERS signatures**:
  - Resistant strains: Distinct Raman peaks
  - ML training on resistant vs. susceptible

**Challenge**:
- Genotypic (AMR genes) detection harder with SERS
- â†’ Combine with CN-TAR or SENSR for gene detection

**3. Rapid Species ID for Metagenomics Validation**:

**Workflow**:
```
Metagenomics (Week 1):
  - Community analysis
  - "High E. coli abundance in Site A"
  â†“
P-FS Validation (Week 2):
  - On-site sampling at Site A
  - Fidget spinner + SERS
  - "Confirmed: E. coli dominant"
  â†“
Targeted intervention
```

**4. Resource-Limited Settings**:

**ë„ì‹¬ ì§€ì—­ë„ "ìì› ì œí•œ" ë  ìˆ˜ ìˆìŒ**:
- ì•¼ì™¸ ëª¨ë‹ˆí„°ë§ (ê³µì›, ê°•ë³€)
- ì´ë™ì‹ ê²€ì‚¬ (Mobile testing van)
- ê¸´ê¸‰ ìƒí™© (ì •ì „, ì¬ë‚œ)

**P-FS ì¥ì **:
- No electricity
- Minimal training
- Results in <30ë¶„

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Centrifugal Microfluidics**

**ì›ë¦¬**:
- **Centrifugal force**: F = mÏ‰Â²r
  - m = mass
  - Ï‰ = angular velocity
  - r = radius

**Fidget spinner**:
- Rotation speed: 3,000-6,000 RPM (ì†ìœ¼ë¡œ)
- â†’ Centrifugal force sufficient for:
  - Cell pelleting
  - Plasma separation (blood)
  - Bead-based DNA extraction

**Microfluidic design**:
- **Channels**: Sample flow paths
- **Chambers**: Reaction zones, waste
- **Valves**: Passive (burst valves, siphon valves)

**2. Surface-Enhanced Raman Spectroscopy (SERS)**

**Physics**:
- **Raman scattering**: Inelastic photon scattering
  - Stokes shift: Î»_scattered > Î»_incident
  - Anti-Stokes: Î»_scattered < Î»_incident

**Enhancement mechanisms**:
1. **Electromagnetic (EM)**:
   - Surface plasmons on metal nanoparticles
   - Local electric field â†‘â†‘
   - Enhancement: 10â´-10â¸
2. **Chemical (Charge transfer)**:
   - Molecule-metal electron transfer
   - Enhancement: 10-100

**SERS substrates**:
- **Colloidal nanoparticles**: Au, Ag
- **Nanostructured surfaces**: Arrays, roughened
- **"Hot spots"**: Gaps between nanoparticles (1-10 nm)
  - Enhancement max at hot spots

**3. Raman Spectroscopy for Bacteria**

**Advantages**:
- **Label-free**: No staining
- **Non-destructive**: Live cells ê°€ëŠ¥
- **Fingerprint**: Unique spectrum per species
- **Fast**: ìˆ˜ ì´ˆ-ë¶„ (spectrum acquisition)

**Challenges**:
- **Weak signal**: Raman scattering íš¨ìœ¨ ë‚®ìŒ (â†’ SERS í•„ìš”)
- **Fluorescence interference**: ì¼ë¶€ bacteria
- **Standardization**: Spectrum variability (growth conditions)

**Typical bacterial Raman peaks**:
| Wavenumber (cmâ»Â¹) | Assignment |
|-------------------|------------|
| 730 | Adenine |
| 785 | DNA/RNA bases |
| 1003 | Phenylalanine |
| 1250-1350 | Amide III (protein) |
| 1450 | CHâ‚‚ bending (lipids) |
| 1655 | Amide I (protein) |

**4. Machine Learning for Spectral Classification**

**Pipeline**:
```
Raw SERS spectra
  â†“
Preprocessing:
  - Baseline correction (polynomial fitting)
  - Normalization (total area, peak intensity)
  - Smoothing (Savitzky-Golay filter)
  â†“
Feature extraction:
  - Peak picking
  - Principal Component Analysis (PCA)
  - Peak intensity ratios
  â†“
Classification:
  - Support Vector Machine (SVM)
  - Random Forest
  - Convolutional Neural Network (CNN) for raw spectra
  â†“
Species prediction + confidence score
```

**Training data**:
- Reference strains: 10-100 spectra each
- Clinical isolates: Expand diversity
- Cross-validation: 5-10 fold

**Performance metrics**:
- Accuracy, Precision, Recall
- Confusion matrix (misclassifications)

**5. Point-of-Care Diagnostics for Bacteria**

**Requirements**:
| Criteria | Target | P-FS |
|----------|--------|------|
| **Time** | <1 hour | âœ… 10-30ë¶„ |
| **Cost** | <$10 | âœ… ~$5 (estimated) |
| **Sensitivity** | 10Â³-10âµ CFU/mL | âœ… (SERS ultra-sensitive) |
| **Specificity** | >95% | âœ… (ML-based) |
| **Equipment** | Portable | âœ… Hand-powered |
| **Electricity** | Optional | âœ… None! |

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸** (ìš°ì„ ìˆœìœ„):

1. "**SERS signatureë¡œ AMR ì˜ˆì¸¡**ì´ ê°€ëŠ¥í•œê°€ìš”? ì˜ˆë¥¼ ë“¤ì–´ MRSA vs. MSSAë¥¼ SERS spectrumìœ¼ë¡œ êµ¬ë³„? (mecA ë°œí˜„ â†’ PBP2a â†’ cell wall change)"

2. "P-FSë¥¼ **í™˜ê²½ ìƒ˜í”Œ** (air filter rinse, wastewater)ì— ì ìš©í–ˆì„ ë•Œ, ë³µì¡í•œ matrix (ë‹¤ì–‘í•œ species mixture)ì—ì„œë„ species IDê°€ ê°€ëŠ¥í•œê°€ìš”?"

3. "**Portable Raman spectrometer**ì˜ ë¹„ìš©ê³¼ í¬ê¸°ëŠ”? Field deploymentë¥¼ ìœ„í•œ í˜„ì‹¤ì ì¸ ì˜µì…˜ì´ ìˆë‚˜ìš”?"

4. "SERS + ML ëª¨ë¸ì„ **ìƒˆë¡œìš´ species/strains**ì— í™•ì¥í•˜ë ¤ë©´? Transfer learning? ë„ì‹¬ í™˜ê²½ ê· ì£¼ë¡œ retraining?"

5. "**Quantification**ì´ ê°€ëŠ¥í•œê°€ìš”? Bacterial load (CFU/mL) estimation?"

**Collaboration ì œì•ˆ**:
"ì €ëŠ” ë„ì‹¬ AMR ê°ì‹œë¥¼ ìœ„í•´ ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ë¥¼ ì‚¬ìš©í•˜ëŠ”ë°, **P-FSë¡œ ë¹ ë¥¸ species validation**ì„ í•˜ê³  ì‹¶ìŠµë‹ˆë‹¤. UNIST-ì„œìš¸ collaborative study ê°€ëŠ¥í• ê¹Œìš”?"

**í† ë¡  ì˜ˆìƒ**:
- **SERS-based AMR phenotyping**: Realistic?
  - Metabolic byproducts (e.g., Î²-lactamase activity?)
  - Cell surface changes
- **Smartphone integration**: Portable Raman + smartphone camera?
- **Commercial pathway**: FDA approval for clinical use?
- **Field robustness**: Temperature, humidity effects on SERS?

**ë„¤íŠ¸ì›Œí‚¹ ì „ëµ**:
- â­â­â­ **ë§¤ìš° í˜ì‹ ì  â†’ ë„¤íŠ¸ì›Œí‚¹ í•„ìˆ˜!**
- ë°œí‘œ í›„ ì§ˆë¬¸ (Environmental sample application)
- UNIST ê°€ê¹Œì›€ (ìš¸ì‚°) â†’ Lab visit ì œì•ˆ
- Potential collaboration: "Urban microbiome monitoring with P-FS"

---

### ğŸ”¹ ë°œí‘œ 4 (15:05-15:30)

**ì—°ì‚¬**: Moo-seung Lee (ì´ë¬´ìŠ¹)
**ì†Œì†**: KRIBB, Infectious Disease Research Center
**ì œëª©**: Diagnosis and treatment of enterohaemorrhagic *Escherichia coli* shiga toxin-mediated hemolytic uremic syndrome

#### ìµœê·¼ ì—°êµ¬ ë°°ê²½

Lee ë°•ì‚¬ëŠ” **Shiga toxinê³¼ HUS (hemolytic uremic syndrome) ì „ë¬¸ê°€**ì…ë‹ˆë‹¤.

**ìµœì‹  ì—°êµ¬: Graphene FET Biosensor (2025)**

**ì œëª©**: "An ultrasensitive diagnostic system for minuscule level of hemolytic uremic syndrome"

**Graphene-based Field-Effect Transistor (FET) Biosensor**:
- **ê²€ì¶œ í•œê³„**: Femtogram (fg) level (10â»Â¹âµ g)
- **Specificity**: ë§¤ìš° ë†’ìŒ
- **Label-free**: Fluorophore ë¶ˆí•„ìš”
- **Real-time**: Electrical signal ì§ì ‘ ì¸¡ì •

**ì´ì „ ì—°êµ¬ (2018, 2021)**:
- "Experimental in vivo models of bacterial Shiga toxin-associated HUS" (Review)
- "Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury"

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš©

**1. Shiga Toxin & HUS**

**Enterohemorrhagic E. coli (EHEC)**:
- **Serotypes**: O157:H7 (most common), O104:H4, O26, O111
- **Transmission**: Contaminated food (beef, vegetables), water
- **Symptoms**:
  - Bloody diarrhea (hemorrhagic colitis)
  - Abdominal cramps
  - â†’ HUS (5-10% of cases, especially children)

**HUS (Hemolytic Uremic Syndrome)**:
- **Triad**:
  1. **Hemolytic anemia**: RBC lysis
  2. **Thrombocytopenia**: Platelet ê°ì†Œ
  3. **Acute renal failure**: Kidney damage
- **Mortality**: 3-5% (higher in children <5ì„¸)
- **Long-term**: Chronic kidney disease (25-30%)

**Shiga Toxin (Stx)**:
- **Types**: Stx1, Stx2 (Stx2 more severe)
- **Structure**:
  - A subunit (enzymatic, RNA N-glycosidase)
  - B subunit (pentamer, binds Gb3 receptor)
- **Mechanism**:
  - Binds Gb3 on endothelial cells (kidney, brain, colon)
  - Internalized â†’ Retrograde transport to ER
  - A subunit â†’ 28S rRNA cleavage â†’ Ribosome inactivation
  - â†’ Protein synthesis â†“ â†’ Cell death

**2. Current Diagnostics**

**Problems**:
- **Culture**: 24-72ì‹œê°„
- **Toxin detection (ELISA)**: 4-8ì‹œê°„, moderate sensitivity
- **PCR (stx genes)**: 3-5ì‹œê°„, requires equipment
- **Early diagnosis critical**: HUS prevention (no antibiotics - toxin release â†‘)

**3. Graphene FET Biosensor**

**Field-Effect Transistor (FET)**:
- **Semiconductor device**: Current modulation by electric field
- **Graphene**: Single-layer carbon (2D material)
  - High electron mobility
  - Large surface area
  - Biocompatible

**Biosensor Design**:
```
Graphene channel (FET)
  â†“
Functionalized with anti-Stx antibody
  â†“
Sample applied (serum, stool filtrate)
  â†“
Stx binds antibody
  â†“
Surface charge change
  â†“
Channel conductance change
  â†“
Electrical signal (real-time)
```

**Performance**:
- **Sensitivity**: fg/mL (vs. ELISA ng/mL)
- **Speed**: ìˆ˜ ë¶„
- **Specificity**: Anti-Stx antibody-dependent

**4. Treatment Strategies**

**Current (supportive)**:
- **Hydration**: IV fluids
- **Dialysis**: Acute renal failure
- **Blood transfusion**: Severe anemia
- **âš ï¸ No antibiotics**: Toxin release ì¦ê°€

**Emerging therapies** (Lee's research):
- **O-GlcNAcylation inhibitors**:
  - O-GlcNAc transferase (OGT) inhibition
  - Protects cells from Stx toxicity (2021 publication)
- **Toxin neutralizers**:
  - Anti-Stx antibodies (monoclonal)
  - Gb3 analogs (decoy receptors)
- **Ribosome protection**:
  - Inhibit retrograde transport

#### ë‹¹ì‹ ì˜ ì—°êµ¬ì™€ì˜ ì—°ê²°ì 

**ë„ì‹¬ AMR ê°ì‹œì™€ì˜ ì—°ê²° (ê°„ì ‘)**:

**1. EHEC in Urban Environment**:

**Sources**:
- **Food contamination**: Restaurants, markets
- **Water**: Runoff, sewage overflow
- **Contact**: Petting zoos, farms

**Surveillance**:
- Metagenomicsì—ì„œ **stx genes** ê²€ì¶œ
  - stx1, stx2 variants
- **eae gene** (intimin, adhesion)
- Serotyping markers

**2. Graphene FET Technology Transfer**:

**AMR gene detection**:
- Functionalize graphene with **AMR gene-specific probes**
  - mecA, blaNDM, mcr-1
- Direct electrical detection (no amplification)
- **Ultra-sensitive** environmental monitoring

**Potential**:
```yaml
Urban Water AMR Biosensor (Graphene FET):
  Target genes:
    - mecA (MRSA)
    - blaNDM (Carbapenemase)
    - stx2 (EHEC virulence)

  Workflow:
    1. Water sample (100 mL)
    2. Filtration & DNA extraction
    3. Apply to Graphene FET array
    4. Real-time electrical readout (10-30ë¶„)
```

**3. Integration with Metagenomics**:

**Discovery â†’ Validation**:
```
Metagenomics: "stx2 detected in river sample"
  â†“
Graphene FET: On-site confirmation (30ë¶„)
  â†“
Public health alert
```

#### í•„ìˆ˜ ë°°ê²½ ì§€ì‹

**1. Shiga Toxin Mechanism**

**Detailed pathway**:
```
EHEC colonizes colon
  â†“
Stx1/Stx2 released
  â†“
Absorbed into bloodstream
  â†“
Binds Gb3 (globotriaosylceramide) on endothelial cells
  â†“ (Kidney glomeruli, brain)
Receptor-mediated endocytosis
  â†“
Retrograde transport (endosome â†’ Golgi â†’ ER)
  â†“
A subunit translocates to cytosol
  â†“
Cleaves adenine-4324 in 28S rRNA
  â†“
60S ribosomal subunit inactivation
  â†“
Protein synthesis STOP
  â†“
Cell death (apoptosis/necrosis)
  â†“
Endothelial damage â†’ Microthrombi
  â†“
HUS (hemolysis + thrombocytopenia + renal failure)
```

**2. Gb3 Receptor**

**Structure**: Glycosphingolipid
- Ceramide (lipid anchor)
- Glucose-Galactose-Galactose (sugar headgroup)

**Distribution**:
- **High**: Kidney (glomerular endothelium), Brain, Colon
- **Low**: Most other tissues
- â†’ Explains HUS tropism

**B subunit binding**:
- Pentameric B subunit
- Each B binds Gb3
- High avidity (multivalent binding)

**3. Graphene Electronics**

**Graphene properties**:
- **2D material**: Single atomic layer carbon
- **Zero bandgap**: Semi-metal
- **High mobility**: Electrons move fast
- **Ambipolar**: Both electrons and holes as carriers

**FET principle**:
```
Source ----[Graphene channel]---- Drain
              â†‘
            Gate (electrolyte)
```

**Sensing**:
- Target binds to graphene surface
- Surface potential changes
- â†’ Gate effect
- â†’ Channel conductance (G = I/V) changes
- â†’ Electrical signal

**Advantages**:
- **Label-free**: No fluorophores, enzymes
- **Real-time**: Immediate electrical response
- **Sensitive**: Single molecule detection possible
- **Portable**: Small device

**4. Biosensor Functionalization**

**Surface chemistry**:
```
Graphene
  â†“
Pyrene-based linker (Ï€-Ï€ stacking)
  â†“
Carboxyl groups (-COOH)
  â†“
EDC/NHS coupling
  â†“
Anti-Stx antibody (covalent attachment)
```

**Specificity**:
- Antibody selectivity
- Non-specific binding minimization (BSA blocking)

**5. O-GlcNAcylation**

**Post-translational modification**:
- O-linked Î²-N-acetylglucosamine (O-GlcNAc)
- Added to Ser/Thr residues (like phosphorylation)
- **OGT (O-GlcNAc transferase)**: Add O-GlcNAc
- **OGA (O-GlcNAcase)**: Remove

**Role in Shiga toxin response**:
- Lee's finding: **OGT inhibition protects cells**
- Mechanism: Unknown (ongoing research)
- Hypothesis: Affects retrograde transport or ribosome?

#### ì˜ˆìƒ ì§ˆë¬¸ & í† ë¡  í¬ì¸íŠ¸

**ë‹¹ì‹ ì´ ë¬¼ì–´ë³¼ ì§ˆë¬¸**:

1. "Graphene FET ê¸°ìˆ ì„ **AMR genes** (mecA, blaNDM) ê²€ì¶œì— ì ìš©í•  ìˆ˜ ìˆì„ê¹Œìš”? Antibody ëŒ€ì‹  DNA probe ì‚¬ìš©?"

2. "**Environmental samples** (ê°•ë¬¼, í•˜ìˆ˜)ì—ì„œ Stx ë˜ëŠ” EHECë¥¼ Graphene FETë¡œ ê²€ì¶œí•œ ê²½í—˜ì´ ìˆë‚˜ìš”?"

3. "**Multiplexing**ì´ ê°€ëŠ¥í•œê°€ìš”? í•˜ë‚˜ì˜ chipì— ì—¬ëŸ¬ graphene channels (ê°ê° ë‹¤ë¥¸ antibody)?"

4. "OGT inhibitorsì˜ **in vivo efficacy**ëŠ”? Animal modelì—ì„œ HUS prevention?"

**í† ë¡  ì˜ˆìƒ**:
- **Graphene FET commercialization**: Cost, manufacturing?
- **Regulatory hurdles**: Biosensor approval for clinical use?
- **EHEC outbreak response**: Rapid on-site testing

**ë„¤íŠ¸ì›Œí‚¹**:
- ì¤‘ê°„ ìš°ì„ ìˆœìœ„ (ê¸°ìˆ ì€ í¥ë¯¸ë¡­ì§€ë§Œ, ì—°êµ¬ focusê°€ ì•½ê°„ ë‹¤ë¦„)
- Graphene FET ê¸°ìˆ  í˜‘ë ¥ ê°€ëŠ¥ì„± íƒìƒ‰

---

### ğŸ”¹ ë°œí‘œ 5 (15:30-15:50)

**ì—°ì‚¬**: Namil Lee (ì´ë‚¨ì¼)
**ì†Œì†**: KAIST
**ì œëª©**: Unlocking the full potential of *Streptomyces* by synergizing systems and synthetic biology

#### ì—°êµ¬ ë°°ê²½

**Streptomyces**:
- **"Antibiotic factory"**: ìì—°ê³„ í•­ìƒì œì˜ 50-60% ìƒì‚°
- **Secondary metabolites**: Streptomycin, tetracycline, erythromycin, etc.
- **Synthetic biology target**: Pathway engineering for novel antibiotics

#### ì˜ˆìƒ ë°œí‘œ ë‚´ìš© (ê°„ëµ)

**1. Streptomyces as antibiotic source**
- Natural product biosynthesis
- BGCs (Biosynthetic Gene Clusters)

**2. Systems biology approach**:
- Genome-scale metabolic models
- Transcriptomics, proteomics
- Pathway prediction

**3. Synthetic biology tools**:
- CRISPR-Cas9 editing
- Heterologous expression
- Pathway optimization

**4. Novel antibiotic discovery**:
- Silent BGC activation
- Hybrid antibiotics

#### ì—°ê²°ì  (ê°„ì ‘):

**AMR ê´€ì **:
- **New antibiotics from Streptomyces** â†’ AMR ëŒ€ì‘
- ë„ì‹¬ í† ì–‘ Streptomyces metagenomics â†’ Novel BGC discovery

**Priority**: ë‚®ìŒ (S4, S8 focus í›„ ì—¬ìœ  ìˆìœ¼ë©´)

---

## ğŸ§  ì„¸ì…˜ ì „ì²´ í•µì‹¬ ìš”ì•½

### S8ì˜ í•µì‹¬ ë©”ì‹œì§€

**"AMR ì§„ë‹¨ì€ ë¹ ë¥´ê³ , í˜„ì¥ì—ì„œ, ì €ë ´í•˜ê²Œ!"**

| Technology | Speed | Portability | AMR Application |
|------------|-------|-------------|-----------------|
| **SENSR** (Lee) | 30-50ë¶„ | Moderate (fluorescence reader) | AMR gene RNA detection |
| **CN-TAR** (Lim) | <2ì‹œê°„ | âœ… Portable isothermal device | **Airborne MRSA/VRE** â­ |
| **P-FS** (Cho) | 10-30ë¶„ | âœ…âœ… Hand-powered! | Species ID, AMR phenotype? |
| **Graphene FET** (Lee M) | <30ë¶„ | âœ… Small device | Toxin/Gene detection |

### ë„ì‹¬ AMR ê°ì‹œ í†µí•© ì „ëµ

```yaml
Tier 1 - Broad Surveillance (Weekly-Monthly):
  - Metagenomics: Community profiling, AMR gene discovery

Tier 2 - Targeted Monitoring (Daily):
  - CN-TAR: Airborne MRSA/VRE at hotspots
  - P-FS: Species confirmation

Tier 3 - Rapid Validation (On-demand):
  - SENSR: RNA-based active AMR detection
  - Graphene FET: Ultra-sensitive confirmation
```

### Metagenomics Markers from S8

```yaml
Detection Targets:
  Cell-free RNA (SENSR):
    - mecA transcripts (active MRSA)
    - carbapenemase mRNA (blaNDM, blaKPC)

  DNA (CN-TAR):
    - mecA gene (MRSA)
    - vanA/vanB (VRE)
    - Expandable to blaNDM, mcr-1

  SERS Phenotype (P-FS):
    - Species: E. coli, S. aureus, P. aeruginosa
    - Potential AMR signatures (cell wall changes)

  Toxins/Proteins (Graphene FET):
    - Shiga toxin
    - Adaptable to AMR proteins?
```

---

## ğŸ“š ì‚¬ì „ ì½ê¸° (ìš°ì„ ìˆœìœ„)

### í•„ìˆ˜

1. **Eun-Kyung Lim (2025)** - "Onsite detection of airborne antibiotic-resistant bacteria via Cas9 nickase-triggered amplification reactions"
   - ìµœì‹ ! ê¼­ ì½ê¸°

2. **Yoon-Kyoung Cho (2025)** - "Nanoplasmonic SERS on fidget spinner for digital bacterial identification" (Microsystems & Nanoengineering)

3. **Jeong Wook Lee (2020)** - SENSR technology (Nature Biomedical Engineering)

### ì¶”ì²œ

4. **RCA (Rolling Circle Amplification) Review** - ë©”ì»¤ë‹ˆì¦˜ ì´í•´

5. **SERS for bacteria** - Raman spectroscopy ê¸°ì´ˆ

---

## ğŸ¤ ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸ (Top Priority)

### Must Ask!

1. **[Lim]** "CN-TARë¥¼ ë„ì‹¬ ëŒ€ê¸° ìƒ˜í”Œì— ì ìš©í•  ë•Œ air sampling ë°©ë²•ê³¼ multiplex expansion ê°€ëŠ¥ì„±ì€?"

2. **[Cho]** "P-FS SERSë¡œ AMR phenotype (MRSA vs. MSSA) êµ¬ë³„ì´ ê°€ëŠ¥í•œê°€ìš”? í™˜ê²½ ìƒ˜í”Œ ì ìš© ê²½í—˜ì€?"

3. **[Lee J]** "SENSRë¥¼ metatranscriptomic ìƒ˜í”Œì— ì ìš© ì‹œ pre-amplification í•„ìš” ì—¬ë¶€ì™€ multiplex í•œê³„ëŠ”?"

### Backup

4. **[Lee M]** "Graphene FETë¥¼ AMR gene detectionìœ¼ë¡œ í™•ì¥ ê°€ëŠ¥í•œê°€ìš”?"

5. **[Lee N]** "ë„ì‹¬ í† ì–‘ Streptomycesì—ì„œ novel BGC discovery?"

---

## ğŸ¤ ë„¤íŠ¸ì›Œí‚¹ ìš°ì„ ìˆœìœ„

### 1ìœ„: Eun-Kyung Lim (KRIBB) â­â­â­

**Why**: Airborne AMR detection = ì—°êµ¬ ì§ê²°!

**Strategy**:
- ë°œí‘œ ì§í›„ ì§ˆë¬¸
- Collaborative study ì œì•ˆ (Seoul subway CN-TAR monitoring)
- KRIBB ë°©ë¬¸ ì•½ì†

### 2ìœ„: Yoon-Kyoung Cho (UNIST) â­â­â­

**Why**: P-FS í˜ì‹ ì , portable

**Strategy**:
- Environmental sample application ë…¼ì˜
- SERS-based AMR phenotyping ê°€ëŠ¥ì„±
- UNIST lab visit

### 3ìœ„: Jeong Wook Lee (POSTECH) â­â­

**Why**: SENSR metatranscriptomics ì‘ìš©

**Strategy**:
- RNA-based active AMR monitoring
- Technical consultation

---

## âš¡ ì„¸ì…˜ ë‹¹ì¼ ì²´í¬ë¦¬ìŠ¤íŠ¸

### ì‚¬ì „ (ì „ë‚ )
- [ ] Lim (2025), Cho (2025) ë…¼ë¬¸ ì½ê¸°
- [ ] CN-TAR, P-FS, SENSR ë©”ì»¤ë‹ˆì¦˜ ì •ë¦¬
- [ ] ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸ final check

### ë‹¹ì¼ (10/27 ì˜¤í›„)
- [ ] ì ì‹¬ í›„ Rm 301+302 ë¯¸ë¦¬ ë„ì°© (13:40)
- [ ] ì•ìë¦¬ ì„ ì 
- [ ] ëª…í•¨ 10ì¥ ì¤€ë¹„
- [ ] ë…¸íŠ¸ + ë³¼íœ

### ì„¸ì…˜ ì¤‘
- [ ] ê° ë°œí‘œ í•µì‹¬ í¬ì¸íŠ¸ ë©”ëª¨
- [ ] íŠ¹íˆ Lim, Cho ë°œí‘œ ì§‘ì¤‘
- [ ] Slide ì‚¬ì§„ (í—ˆìš©ì‹œ)

### ì§í›„
- [ ] Lim, Choì™€ ì§ì ‘ ëŒ€í™”
- [ ] Collaborative study ì œì•ˆ
- [ ] ëª…í•¨ êµí™˜ + ë’·ë©´ ë©”ëª¨
- [ ] Poster session ì•½ì†

---

**ì˜ˆìƒ í•™ìŠµ ì„±ê³¼**:
âœ… 4ê°€ì§€ í˜ì‹  ì§„ë‹¨ ê¸°ìˆ  ìŠµë“ (SENSR, CN-TAR, P-FS, Graphene FET)
âœ… ë„ì‹¬ AMR ê°ì‹œ ì¦‰ì‹œ ì ìš© ê°€ëŠ¥í•œ í”Œë«í¼ íŒŒì•…
âœ… KRIBB, UNIST ì—°êµ¬ìì™€ collaboration ê¸°íšŒ
âœ… Portable diagnosticsì˜ ë¯¸ë˜ ë¹„ì „

**í•µì‹¬ Takeaway**: "ì‹¤í—˜ì‹¤ì—ì„œ í˜„ì¥ìœ¼ë¡œ!" â†’ Point-of-care AMR detection ì‹œëŒ€
